Physician profile
Yong He
NPI 1710979133
$19,474.46
in general payments reported to CMS, 2019-2025
63 companies · $3,032 in 2025
The $3,032 reported for 2025 was more than what 79% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,638 · 2020: $2,634 · 2021: $2,846 · 2022: $2,005 · 2023: $3,083 · 2024: $3,237 · 2025: $3,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,079 · Education: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,078.66 |
| Education | $272.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,689.60 | 2020-2025 | |
| Ucb, INC. | $1,684.50 | 2019-2025 | Briviact, Rystiggo, Fintepla |
| Novartis Pharmaceuticals Corporation | $1,117.50 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $1,026.12 | 2019-2025 | Nuplazid, Daybue |
| Sk Life Science, INC. | $909.71 | 2020-2025 | Xcopri |
| Genentech USA, INC. | $866.00 | 2019-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Eisai INC. | $865.54 | 2019-2025 | |
| Biogen, INC. | $834.26 | 2019-2025 | Tysabri, Vumerity, Skyclarys |
| Amgen INC. | $727.75 | 2019-2025 | Uplizna |
| Pfizer INC. | $651.19 | 2019-2025 | |
| Genzyme Corporation | $643.37 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $599.11 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Amneal Pharmaceuticals LLC | $525.90 | 2019-2025 | Rytary, Crexont, Ongentys |
| Emd Serono, INC. | $510.29 | 2019-2025 | |
| Lilly USA, LLC | $435.42 | 2019-2025 | Reyvow, Emgality, Amyvid |
Show all 63 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yong He listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.